Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for Major Depressive Disorder
NCT01066897Phase 4Terminated
- Sponsor
- Stanford University
- Start
- Feb 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pramipexole in major depressive disorder (MDD), sponsored by Stanford University. Started Feb 2010; status: terminated.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01066897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066897.